ÅǸ޴º
Á¦¸ñ | A multicenter phase II study of sorafenib in combination with erlotinibin patients with advanced non-small cell lung cancer (KCSG-0806) | µî·ÏÀÏ | 20160217 | ´Ù¿î·Îµå | |
---|---|---|---|---|---|
A multicenter phase II study of sorafenib in combination with erlotinibin patients with advanced non-small cell lung cancer (KCSG-0806). LUNG CANCER 2016;93:1-8.
|
Copyright ¨Ï chamc, All rights reserved.